CDTX has been in the news 1000% more than usual
Nov 14, 2025, 3:32 PM
0.00%
CDTX has been in the news recently: Cidara Therapeutics Inc. (NASDAQ:CDTX) shares are rising as the company reported a 25% increase in revenue this quarter compared to last year. Merck & Co. Inc. plans to acquire Cidara Therapeutics for $221.50 per share, amounting to approximately $9.2 billion.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.